Insider Trading & Ownership - ARCH Venture Fund X L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ARCH Venture Fund X L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-15
Purchase
2024-02-20
5:37 pm
Prime Medicine Inc.PRMEARCH Venture Partners X LLC
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
3,200,000$6.25$20,000,00015,456,594
(Indirect)
View
2024-02-08
Purchase
2024-02-12
5:43 pm
Sana Biotechnology Inc.SANAARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners IX LLC
ARCH Venture Partners X LLC
10% Owner
1,818,181$5.5$9,999,99622,747,272
(Indirect)
View
2023-09-19
Purchase
2023-09-20
06:15 am
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Partners X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners VII LLC
ARCH Venture Partners VII L.P.
ARCH Venture Fund VII L.P.
ARCH Venture Partners VIII LLC
ARCH Venture Fund VIII Overage L.P.
10% Owner
1,500,000$17$25,500,0003,624,143
(Indirect)
View
2022-10-24
Purchase
2022-10-26
8:01 pm
Prime Medicine Inc.PRMEARCH Venture Partners X LLC
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
800,000$17$13,600,0006,128,297
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-08
Other
2023-12-12
7:52 pm
N/A
N/A
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Partners X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners VII LLC
ARCH Venture Partners VII L.P.
ARCH Venture Fund VII L.P.
ARCH Venture Partners VIII LLC
ARCH Venture Fund VIII Overage L.P.
10% Owner
1,879,654$032,424,564
(Indirect)
View
2023-09-19
Conversion
2023-09-20
06:15 am
N/A
N/A
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Partners X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners VII LLC
ARCH Venture Partners VII L.P.
ARCH Venture Fund VII L.P.
ARCH Venture Partners VIII LLC
ARCH Venture Fund VIII Overage L.P.
10% Owner
17,424,704$03,624,143
(Indirect)
View

Ownership
2023-09-14
9:22 pm
N/A
N/A
Neumora Therapeutics Inc.NMRAARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Partners X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners VII LLC
ARCH Venture Partners VII L.P.
ARCH Venture Fund VII L.P.
ARCH Venture Partners VIII LLC
ARCH Venture Fund VIII Overage L.P.
10% Owner
0$028,045,420
(Indirect)
View
2022-10-24
Conversion
2022-10-26
8:01 pm
N/A
N/A
Prime Medicine Inc.PRMEARCH Venture Partners X LLC
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
41,344,576$06,128,297
(Indirect)
View

Ownership
2022-10-19
8:08 pm
N/A
N/A
Prime Medicine Inc.PRMEARCH Venture Partners X LLC
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
0$011,456,594
(Indirect)
View
2021-07-20
Conversion
2021-07-20
8:53 pm
N/A
N/A
Erasca Inc.ERASARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
NELSEN ROBERT
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
18,794,443$05,527,777
(Indirect)
View

Ownership
2021-07-15
9:06 pm
N/A
N/A
Erasca Inc.ERASARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
NELSEN ROBERT
CRANDELL KEITH
Burow Kristina
GILLIS STEVEN
10% Owner
0$011,055,554
(Indirect)
View
2021-06-21
Conversion
2021-06-23
4:29 pm
N/A
N/A
Verve Therapeutics Inc.VERVARCH Venture Partners X LLC
ARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
CRANDELL KEITH
NELSEN ROBERT
Burow Kristina
GILLIS STEVEN
10% Owner
25,739,146$01,254,405
(Indirect)
View

Ownership
2021-06-16
7:35 pm
N/A
N/A
Verve Therapeutics Inc.VERVARCH Venture Fund X L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners X LLC
CRANDELL KEITH
NELSEN ROBERT
Burow Kristina
GILLIS STEVEN
10% Owner
0$02,508,809
(Indirect)
View
2021-02-08
Conversion
2021-02-10
7:22 pm
N/A
N/A
Sana Biotechnology Inc.SANAARCH Venture Fund X L.P.
CRANDELL KEITH
BYBEE CLINTON
Burow Kristina
GILLIS STEVEN
10% Owner
65,625,000$011,718,750
(Indirect)
View
2021-02-08
Conversion
2021-02-10
7:20 pm
N/A
N/A
Sana Biotechnology Inc.SANAARCH Venture Fund X L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners IX L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners IX LLC
ARCH Venture Partners X LLC
10% Owner
65,625,000$011,718,750
(Indirect)
View

Ownership
2021-02-03
9:30 pm
N/A
N/A
Sana Biotechnology Inc.SANAARCH Venture Fund X L.P.
CRANDELL KEITH
BYBEE CLINTON
Burow Kristina
GILLIS STEVEN
10% Owner
0$044,042,500
(Indirect)
View

Ownership
2021-02-03
9:27 pm
N/A
N/A
Sana Biotechnology Inc.SANAARCH Venture Fund X L.P.
ARCH Venture Fund IX L.P.
ARCH Venture Fund IX Overage L.P.
ARCH Venture Fund X Overage L.P.
ARCH Venture Partners IX Overage L.P.
ARCH Venture Partners X L.P.
ARCH Venture Partners X Overage L.P.
ARCH Venture Partners IX LLC
ARCH Venture Partners X LLC
10% Owner
0$044,042,500
(Indirect)
View